“…It has been shown to be more effective than PUVA photochemotherapy, without the adverse side effect profile of psoralen (Table 1) (Bhatnagar, Kanwar et al, 2007;Yones, Palmer et al, 2007). Evidence-based guidelines suggest that NB-UVB should be used instead of PUVA in both adult and pediatric patients who have treatment-resistant disease, widespread involvement (BSA > 10-20%), or disease that severely affects quality of life Gawkrodger, Ormerod et al, 2008;Silverberg, 2010). Furthermore, NB-UVB is suggested as the best choice for generalized disease, with topical immunomodulators (i.e., pimecrolimus cream or tacrolimus ointment) reserved for localized patches (Stinco, Piccirillo et al, 2009).…”